
Join to view full profile
900 W Faris Rd2ND floorGreenville, SC 29605
Phone+1 864-455-8898
Fax+1 864-455-5164
Dr. Crosswell is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2006
University of Louisville School of MedicineResidency, Pediatrics, 1997 - 2000
University of South Carolina School of MedicineClass of 1997
Medical University of South CarolinaClass of 1997
Certifications & Licensure
NC State Medical License 2014 - 2027
SC State Medical License 2000 - 2027
WV State Medical License 2015 - 2016
GA State Medical License 2003 - 2007
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013, 2015-2017
Publications & Presentations
PubMed
- 9 citationsFinancial distress and medical financial hardship among young adult survivors of blood cancer.Susan K Parsons, Rachel Murphy-Banks, Angie Mae Rodday, Michael E Roth, Kimberly Miller
JNCI Cancer Spectrum. 2024-09-02 - 5 citationsBrentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1.Howland E Crosswell, Ann S LaCasce, Nancy L Bartlett, David J Straus, Kerry J Savage
Haematologica. 2024-03-01 - 2 citationsComparing Barriers and Facilitators to Adolescent and Young Adult Clinical Trial Enrollment Across High- and Low-Enrolling Community-Based Clinics.Elizabeth J Siembida, Holli A Loomans-Kropp, Irene Tami-Maury, David R Freyer, Lillian Sung
The Oncologist. 2022-05-06
Press Mentions
Seattle Genetics Highlights Additional Analyses from ECHELON-1 Phase 3 Clinical Trial of ADCETRISDecember 2nd, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: